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Background: The aim of this study is to explore the values of enhanced CT and oral contrast-enhanced ultrasonography
on preoperative T stage in gastric carcinoma.
Methods: Forty patients with gastric carcinoma, including 27 males and 13 females, were confirmed by endoscopy,
operation, and pathology. The median age of these patients was 49 years old (25 to 73 years). There were 19 cases of
well-differentiated adenocarcinoma, 13 cases of poorly differentiated adenocarcinoma, 5 cases of signet ring cell
carcinoma, and 4 cases of mucinous adenocarcinoma by pathology. All these patients were examined by both enhanced
CT and ultrasound examination simultaneously 1 week before surgery. T staging in all these gastric carcinomas
was carried out by enhanced CT or oral contrast-enhanced ultrasonography, respectively, or by both of them. The
statistical difference between T stage by imaging and pathological T stage was analyzed.
Results: In this study, there were 5 cases with T1 stage, 9 cases with T2 stage, 20 cases with T3 stage, and 6 cases
with T4 stage by pathology; 5 cases with T1 stage, 7 cases with T2 stage, 22 cases with T3 stage, and 6 cases with
T4 stage by enhanced CT imaging with an accuracy of 75.00%; 6 cases with T1 stage, 7 cases with T2 stage, 22 cases
with T3 stage, and 5 cases with T4 stage by ultrasonography examination, with an accuracy of 77.50%; and 4 cases with
T1 stage, 10 cases with T2 stage, 19 cases with T3 stage, and 7 cases with T4 stage by both enhanced CT imaging and
ultrasonography examination, with an accuracy of 85.00%. The accuracy of T staging in gastric carcinoma by both
enhanced CT and ultrasound was higher than that either by enhanced CT or by ultrasound, respectively (P < 0.05). The
anastomosis degree of the gastric carcinoma between enhanced CT and ultrasonography was κ = 0.404.
Conclusions: Combination diagnosis of enhanced CT and oral contrast-enhanced ultrasonography is helpful to improve
the accuracy of T staging of gastric carcinoma before operations.
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Gastric cancer is the fourth most common cancer in the
world, and the mortality rate ranks second in both sexes
worldwide. Although the incidence and mortality rates
of gastric cancer have slowly declined in many countries,
it is still a serious threat to the safety and health of pa-
tients [1]. Clinical studies have shown that the survival* Correspondence: luoyahong2008@163.com
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are closely related to gastric wall invasion (T staging),
lymph node metastasis (N staging), and distant organ
metastasis of gastric tumors (M staging) [2]. If stomach
cancer is accurately diagnosed at an early stage, followed
by a timely surgery, there is a good chance for patients to
be cured and to live for a long time. Even for patients with
advanced gastric cancer at the later stages, obtaining an
accurate diagnosis and precise staging, the survival time
can be extended by chemotherapy or neoadjuvant chemo-
therapy. Therefore, the preoperative accurate evaluation
for T staging of gastric cancer followed by clinical auxiliary
therapy to gastric cancer patients relies on the preciseis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vival rates and survival time of patients with gastric can-
cer. Undoubtedly, it is an important issue for clinical
doctors [3,4].
Medical imaging has been the main method for sta-
ging of gastric cancer. Currently, the methods commonly
used for gastric cancer staging are multidetector com-
puted tomography (MDCT), MRI, endoscopic ultrason-
ography (EUS), abdominal ultrasound, PET-CT, and
other methods [5]. Enhanced scanning of MDCT has be-
come the preferred method for gastric cancer staging
due to the high spatial resolution, tissue resolution, and
three-dimensional reconstruction techniques. However,
the shortcomings of MDCT in the staging of gastric can-
cer are limited values in the evaluation of T1 gastric can-
cer staging and gastric lymph node metastasis, with
limited values of 44.4% to 83.7% and 64.0% to 78.2%, re-
spectively [6,7]. Therefore, the combination of enhanced
MDCT scanning and other imaging methods to enhance
the accuracy of staging diagnosis of gastric cancer for T
stage and N stage is undoubtedly an important strategy
for gastric cancer therapy.
Enhanced MRI scanning has a higher scanning reso-
lution on soft tissue than enhanced MDCT scanning;
however, the longer scanning time is not conducive to
overcome peristalsis of the stomach. Additionally, the rela-
tively expensive fees also contribute to the restriction of
MRI application on staging of gastric cancer. Recently,
EUS has increasingly become the best method combined
with stomach MDCT for T staging of gastric cancer be-
cause of its better resolution at the stomach level. How-
ever, due to limitations of ultrasound beam attenuation,
T3 or T4 staging of gastric cancer is limited in EUS. Add-
itionally, the discomfort caused by the examination also
limited the application of EUS [8]. The ultrasound imaging
method (transabdominal ultrasound) was the traditional
technique for the examination of the stomach, but it was
once discarded by clinical doctors because of the scan
depth limitations of ultrasound imaging at that time
and especially the reverberation effects and graphic dis-
tortions caused by the retained gas in water filling the
stomach cavity. With the development of ultrasound
equipment and an oral ultrasound contrast agent, oral
echo-ultrasound contrast agents were used in clinics,
which promoted the progress of ultrasound diagnostic
techniques on gastric cancer. Meanwhile, it would pro-
vide a new method for T staging of stomach cancer by
imaging [9,10].
In double contrast-enhanced ultrasonography (DCUS)
applications, Zheng et al. thought there were no statisti-
cally significant differences (P > 0.05) between its accuracy
of T staging (about 77.2%) and EUC’s accuracy (about
74.7%) [11]. Therefore, DCUS may be the best alternative
method for EUS in combination with MDCT in the Tstaging of gastric cancer. In the clinical application of
DCUS, Chen et al. thought, to ensure good premise stom-
ach cavity filling, the accuracy rate of oral echo-type filling
agent ultrasound imaging for gastric staging is about
78.6% while the accuracy rate of DCUS for gastric cancer
staging is 86.7%, and there was no significant difference
between them (P > 0.05) [12]. Thus, we believed that there
is a similar accuracy for the oral echo-type filling agent
ultrasound imaging for gastric cancer staging and DCUS,
but DCUS is considered important in combination with
enhanced MDCT scanning, then oral echo-type filling
agent-enhanced ultrasonography and MDCT scanning. It
is possible to have a higher gastric T staging of comple-
mentary imaging techniques in ‘combination’.
Thus, the study combined and applied two kinds of
imaging methods, such as enhanced MDCT scanning
and oral echo-type filling agent ultrasound imaging, to
discuss the evaluation on the combined application of
two kinds of imaging. The T stages of forty patients with
gastric cancer were diagnosed before surgery, and the re-
sults were compared with the postoperative pathological
T staging results. The value of applying the two kinds of
methods to evaluate the preoperative T staging of gastric
cancer was discussed to them.
Methods
General information
A total of 40 patients with gastric cancer in the Department
of Gastric Surgery of Provincial Tumor Hospital of
Liaoning Province were admitted and included between
July 2012 and January 2013. All of the patients were
confirmed by endoscopy examination and treated by
surgery. The inclusion criteria were as follows: the pa-
tients were identified to have gastric cancer confirmed
by gastroscopy examination, without serious heart and
lung disease and iodine allergies, and they finally had an
operation. Exclusion criteria were as follows: patients
with severe cardiopulmonary disease and iodine aller-
gies, and patients who cannot be operated in the future.
The study has been approved by the Ethics Committee of
Liaoning Cancer Hospital and Institute with trial registra-
tion number 2013055, and all patients signed a written in-
formed consent. All patients were simultaneously given
preoperative CT scan and ultrasound imaging examination
1 week before the operation. The interval of imaging
examination and surgery was between 1 and 7 days, with a
median time of 3.5 days.
Scanning methods
Enhanced CT scanning
A GE Lightspeed 16 multi-slice spiral CT machine (GE
Healthcare, Little Chalfont, UK) is used for enhanced
CT scanning. Patients need to fast for 12 h before CT.
In order to reduce gastrointestinal peristalsis, 15 mg of
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before the examination. In order to expand the stomach
cavity, patients should take 2 to 3 g of gas-generating
agent 10 min before the examination.Ultrasound imaging
A GE Logiq 9 color Doppler ultrasonic diagnostic equip-
ment (GE Healthcare, Little Chalfont, UK) is used for
ultrasound imaging, and a convex array probe is selected
with a frequency of 3 to 7 MHz. Patients should keep an
empty stomach before ultrasound examination or keep
fasting for 12 h before CT or 4 h after CT scanning. Five
minutes before the examination, the patient is asked to
drink about 500 to 800 mL of gastrointestinal ultrason-
ography echo-type ultrasound contrast agents (Dongya
Corporation, Huzhou, Zhejiang). During scanning, if le-
sions are in the cardia, the supine position should be
used; if lesions are in the gastric fundus, gastric body,
or the gastric antrum, the right lateral position is used.
When imaging is not satisfactory, the left lateral, half-
sitting, sitting, and standing position could be used.Table 1 Clinical data of 40 cases of gastric cancer
patients
Clinical data
Median age 49Image observation
Ultrasonography diagnosis was carried out by two senior
doctors who both participated in the ultrasound examin-
ation of the patient and assessed the T staging of gastric
cancer. After the enhanced CT scanning was completed,
another two senior associate professors in diagnostic
radiology made a double-blind diagnosis of the pictures




Gastric antrum 15 (37.5%)
Whole stomach 10 (25.0%)
Gastric body 6 (15.0%)
Gastric antrum gastric body 5 (12.5%)
Gastric cardia and fundus 4 (10.0%)
Pathological typesPathological examination
After the surgery, the gastric specimens were fixed with
formalin, embedded in paraffin, and cut into 4-μm-thick
sections. All the sections were prepared for hematoxylin
and eosin (HE) staining. More than one pathological ex-
pert observed the slices with an optical microscope and
diagnosed the pathological T stage of gastric cancer ac-
cording to TNM staging criteria by the American Joint
Committee on Cancer (AJCC) in 2010.Moderately differentiated adenocarcinoma 19 (47.5%)
Poorly differentiated adenocarcinoma 12 (30.0%)
Mucinous adenocarcinoma 4 (10.0%)
Signet ring cell carcinoma 5 (12.5%)
Borrmann classification
Type I 6 (15.0%)
Type II 10 (25.0%)
Type III 14 (35.0%)
Type IV 10 (25.0%)Statistical analysis
All the data used statistical software SPSS 10.0 (χ2 test).
The sample size in the study was 40 cases, and the χ2
test was used to analyze the differences between them.
P < 0.05 meant there was a statistical significance. Good-
ness of fit was analyzed using consistency test. κ (consistent
coefficient) ≥ 0.7 meant strong goodness of fit, 0.7 > κ ≥ 0.4
meant general goodness of fit, and κ < 0.4 meant weak
goodness of fit.Results
Clinical data
We studied a total of 40 patients in the Provincial
Tumor Hospital of Liaoning Province, with a median
age of 49 years (range 25~73 years). As seen in Table 1,
there were 27 males and 13 females. There were 15 cases
of gastric antrum cancer, 10 cases of whole gastric can-
cer, 6 cases of gastric body cancer, 5 cases of gastric an-
trum and gastric corpus carcinoma, and 4 cases of
gastric fundus gastric cardia cancer. The pathological
types were as follows: 19 cases of moderately differenti-
ated adenocarcinoma, 13 cases of poorly differentiated
adenocarcinoma, 4 cases of mucinous adenocarcinoma,
and 5 cases of signet ring cell carcinoma. Borrmann
types were as follows: type I, 6 cases; type II, 10 cases;
type III, 14 cases; and type IV, 10 cases.
Comparison of T stage by imaging and pathology
There were 40 cases of patients with gastric cancer in
the group. The T stage was confirmed by pathological
diagnosis after operation. Five cases were identified with
clinical stage T1, 9 cases had tumor stage T2, 20 cases
were in stage T3, and 6 cases were in stage T4. T stage
was based on an ultrasound evaluation as follows: 6
cases of T1 stage, 7 cases of T2 stage, 22 cases of T3
stage, and 5 cases of T4 stage. A joint evaluation of T
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cases of T1 stage, 10 cases of T2 stage, 19 cases of T3
stage, and 7 cases of T4 stage (Figures 1, 2, 3, and 4).
The comparison of T stage by pathological (Figure 5)
and radiographic analysis in the group is shown in
Table 2.
As shown in Table 2, the accuracy of T staging deter-
mined by CT, ultrasonography, and ultrasonography in
combination with CT was 75.00%, 77.50%, and 85.00%,
respectively. The enhanced CT scanning combined with
ultrasound imaging had a higher accuracy in the evalu-
ation of preoperative T staging of gastric cancer than the
two methods used alone (P < 0.05).
According to Table 3, the Kappa consistency test result
demonstrated that Kappa equaled 0.404, suggesting weak
goodness of fit in the evaluation of T staging by en-
hanced CT scanning and ultrasound imaging of gastric
cancer.
Comparison of enhanced CT scanning and ultrasound
imaging in T staging of gastric cancer
Forty cases of gastric cancer patients were included in
the group. According to the results of enhanced CT
scanning evaluation of T staging, 5 cases were in T1
stage, 7 cases in T2 stage, 22 cases in T3 stage, and 6
cases in T4 stage. T stage according to ultrasonography
evaluation is as follows: 7 cases in T1 stage, 6 cases in
T2 stage, 22 cases in T3 stage, and 5 cases in T4 stage.
The comparison of both methods in the evaluation of
gastric T stage is shown in Table 3.
Discussion
Surgical operation is still the most effective way to cure
gastric carcinoma. But for early gastric cancer, the tumor
is limited to the mucosal layer, and endoscopic mucosal
resection (EMR) can be implemented locally. Especially,
in the last few years, the rapid development of endo-
scopic mucosal dissection (ESD) expands the indications
for endoscopic surgery. For well-differentiated submuco-
sally invasive carcinoma, tumors with a diameter of less
than 3 cm, without lymph node metastasis, can be
treated by endoscopic surgery. Because of the featuresFigure 1 T1 tumors in lesser curvature of the gastric angle. (a-c) Enhanced
serosa. (d) Ultrasound imaging. Visible lesions were seen in the submucosasuch as less surgical trauma, fewer complications, and
relatively simple operation, it is greatly promoted and
widespread in clinical application. It is only performed
to accurately assess the depth of tumor invasion and
tumor size, which means the accurate T stage, and
whether endoscopic therapy can be adopted in patients.
Thus, preoperative T staging contributes to the appropri-
ate surgical planning. The application of imaging methods
for preoperative T staging of gastric cancer is important
and with outstanding value for clinical treatment. In clin-
ical diagnosis and treatment of gastric cancer, enhanced
CT scanning is the most often applied imaging method for
T staging of gastric cancer [6]. Recently, use of an oral
echo-ultrasound contrast agent for ultrasound diagnosis
of gastric cancer is considered as a very promising imaging
method for T staging [13,14]. Thus, we discussed the value
of the combined use of two methods (enhanced CT scan-
ning and ultrasound imaging) in the evaluation of gastric
cancer before surgery.
CT staging of gastric cancer
Gastric spiral enhanced CT scanning can be used by two
methods, filling the stomach with either water or air in
the clinical setting. In this study, the inflator method is
used. In the evaluation of T staging of gastric cancer,
pathological T1 and T2 T staging of gastric cancer were
evaluated by spiral enhanced CT scanning which could
strengthen the difference between the gastric tumor and
the stomach, but it had a limited evaluation capacity. In
this study, for example, the results showed that the
evaluation accuracy of pathological stages T1 and T2 for
gastric cancer by spiral CT was about 42.86%, which was
consistent with the reported data. In this group of pa-
tients, there were three cases of pathological T1 tumors
diagnosed as T2 stage. In a retrospective analysis, two
cases of endoscopic analysis showed that gastric cancer
cells did not invade the muscles but more extensive infil-
tration of lymphocytes caused the local uplift in the
stomach. There were three cases of pathological T2
stage gastric cancer which were diagnosed as T1 stage.
Retrospective analysis results showed two cases of endo-
scopic gastric cancer cells only in ‘nests’ to change theCT scanning showed a clear gap surrounding the fat and smooth
.
Figure 2 T2 gastric cancer in gastric antrum. (a-c) Enhanced CT scanning showed a clear gap surrounding the fat and smooth serosa. (d) The
ultrasound imaging. Visible lesions invaded the muscle layer.
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ous in the stomach.
Spiral CT scanning has a greater advantage on the
evaluation of T stage of gastric cancer in the pathological
T3 and T4 stages, with an accuracy of about 89% to
98%. This is because the prominent feature of T3 gastric
cancer on the spiral CT image is a blurred change in ser-
osa and fat gap, and this imaging feature has a higher
specificity. The T4 gastric prominent feature on the
spiral CT is a violation of the surrounding organs, and this
indicates that specificity is approaching 100% [15,16]. In
this study, the results showed that the accuracy of spiral
CT evaluation of pathological stages T3 and T4 for gastric
cancer was about 92.31%, which was consistent with that
reported in the literature. In this group of patients, there
were two cases of gastric pathology in T2 stage which
were mistakenly diagnosed as T3 stage. In a retrospective
analysis, in one case, gastric cancer cells did not invade
the serosa as evaluated by endoscopic examination, but
obvious inflammation appeared outside the serosa. One
case of pathological T3 stage was diagnosed as stage T4
gastric cancer (violations of the pancreas). A retro-
spective analysis showed the case was lean; fat tissue
between the stomach and pancreas was meager. Al-
though the endoscopic result showed that gastric can-
cer cells had not violated the pancreas, the CT scan
showed that the gap around the fat tissue disappeared,
which led to misdiagnosis [17].Figure 3 T3 gastric cancer in gastric antrum. (a-c) CT scanning. The nodule
(d) Ultrasound imaging. The visible lesions were invading outside the serosThe staging of gastric cancer by ultrasonography
In the 1970s, oral contrast-enhanced ultrasonography is
considered to be an important diagnostic imaging method
for gastric cancer. Water, milk, and other agents were used
to fill the stomach for clinical ultrasonography. But the time
of filling the stomach cavity is short, the image contrast is
low, and the repeatability is poor, all of which directly re-
strict the clinical application of ultrasound for the diagnosis
of gastric cancer [18]. Then, EUS was used because it can
clearly show the five-layer structure of the stomach from
the mucosa, submucosa, muscle, serosa, and outer layer of
serosa [19,20], and especially has a higher accuracy at the
T1-T2 lesion installments [17]. The restrictive factors of
EUS staging to gastric cancer are due to the attenuation of
the ultrasonic beam which led to the lower accuracy of the
T3-T4 staging of gastric cancer. Meanwhile, EUS examin-
ation was conducted on the basis of endoscopy, and the pa-
tient’s degree of acceptance of it was lower than that of the
oral filling agent ultrasound [21].
In recent years, domestic new echo-type gastrointes-
tinal agents appear as a significant aid in clinical applica-
tion, which received acceptance of clinical and imaging
doctors. Especially, agents are significantly simple, have
effects on the dilatation of the stomach cavity, and have
echo difference in gastric cancer, all of which make oral
echo-type filling agent ultrasound imaging increasingly be-
come an important method for T staging of gastric cancer
[11]. Based on oral echo-type filling agent ultrasounds were visible around the fat space, and serosal surface was rough.
a.
Figure 4 T4 gastric cancer in cardia and gastric fundus. (a-c) CT scanning. The gap around fat tissues disappeared, and the lesion invaded other
structures such as the tail of the pancreas, left gastric artery. (d) Ultrasound imaging. It was visible that lesions invaded surrounding organs.
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ant supplement for MDCT T staging increasingly becomes
a controversial issue [12,22].
In this study, oral echo-type filling agent ultrasound
imaging T staging of gastric cancer was evaluated, and
the overall accuracy reached 77.50%, which was consist-
ent with that reported in the paper [12,23]. In this group
of patients, five cases were in the pathological T1 stage
of gastric cancer. The accuracy reached 100% by ultra-
sound staging. But for pathological T3 and T4 staging of
gastric cancer, the accuracy of this study was about
80.76%, which is lower than that of the enhanced MDCT
scanning (92.31%). We thought that the reason was due
to the lesions being far from the ultrasound probe,Figure 5 The pictures of pathological tissue slices. (A) Tumor invasion was
(C) The lesions were invading outside the serosa. (D) Tumor invasion outsiresulting in a lower spatial resolution. On the other
hand, it was because the movement of the stomach had
interfered with the measurement of blood flow within
the lesion [24,25]. While T3 to T4 gastric T staging is
the advantage of enhanced MDCT scanning, therefore,
we thought that oral contrast-enhanced ultrasonography
and enhanced CT may have greater complementarity.
In this group of patients, two cases of gastric cancer in
pathological T2 stage were diagnosed as T1 stage. The
endoscopic examination showed that although gastric
cancer cells only violated the submucosa, the nest distri-
bution of gastric cancer cells forms a protrusion to the
muscle, which caused the misjudgment of infiltration of
the lesions by imaging. There were two cases oflimited to the submucosa. (B) Tumor invaded into inherent grassroots.
de the serosa was invisible and accompanied by vascular thrombosis.
Table 2 Comparison of 40 cases with gastric cancer by
imaging and pathology
T stage by imaging Pathological T stage Total
T1 T2 T3 T4
Enhanced CT scaning*
T1 2 3 5
T2 3 4 7
T3 2 19 1 22
T4 1 5 6
Ultrasound imaging**
T1 5 1 6
T2 5 2 7
T3 3 17 2 22
T4 1 4 5
Comprehensive imaging***
T1 4 4
T2 1 7 2 10
T3 2 17 19
T4 1 6 7
Total 5 9 20 6 40
*P < 0.05; **P < 0.05; ***P < 0.05.
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endoscopic examination in one case showed that although
gastric cancer cells penetrated the plasma membrane, the
carcinoma outside the serosa showed a scattered distribu-
tion. There were two cases of pathological T4 stage of gas-
tric cancer diagnosed as T3 stage. In one case, the lesions
were located in the antral posterior wall which was away
from the probe, and the lesions’ significant creeping infil-
tration, combined with the patient’s gastric motility, was
very intense and had direct impact on the observation of
the disease.
T staging of gastric cancer by CT scan in combination
with ultrasound imaging
Laparoscopic examination has a very important value for
peritoneal metastasis in the abdominal cavity, which is
the disadvantage for image examinations, such as CT or
ultrasonography. Laparoscopy is applied for the stagingTable 3 Comparison of both methods in the evaluation of
gastric T stage in 40 cases with gastric cancer
Stages by ultrasound
imaging
Stages by CT Total
T1 T2 T3 T4
T1 2 4 6
T2 3 3 1 7
T3 18 4 22
T4 3 2 5
Total 5 7 22 6 40of gastric carcinoma, which can effectively find peritoneal
metastases before surgery, and can give an early open sur-
gical resection. Moreover, it helps to accurately determine
the T staging and contributes to the implementation of
preoperative neoadjuvant chemotherapy. Therefore, the
conventional CT imaging combined with laparoscopic
examination is more helpful and meaningful for accurate
preoperative staging [26].
Enhanced MDCT scanning is currently considered as
the preferred method for T staging of gastric cancer in the
world, but as a complementary staging, it remains to be
further studied [21,27]. This study combined the findings
of Zheng [11] and Chen et al. [12]. Enhanced MDCT
scanning and oral echo agent ultrasound imaging were
combined for the T staging of gastric cancer, and the ac-
curacy reached 85.00%, which was consistent with that
from Venkataraman [28]. The combination of enhanced
CT scanning and ultrasound imaging has a higher accur-
acy in the evaluation of preoperative T staging of gastric
cancer than any method used alone (P < 0.05).
The results in the present study demonstrated that T
staging of gastric cancer based on CT scan and ultrasound
imaging had a weak goodness of fit (Kappa consistency
test κ = 0.404), which demonstrated that the overlapping
of the evaluation by CT scan and ultrasound imaging to
the results of T staging was not high. Thus, if one method
made mistakes in the evaluation of T staging of gastric
cancer, the other method could prompt existing errors
that can improve the accuracy of T staging evaluation. For
this group of patients, enhanced CT scanning had a higher
accuracy (about 92.31%) in evaluating gastric cancer at
pathological T3 and T4 stages. Ultrasound imaging had
the accuracy of about 64.29% for pathological T1 and T2
stages of gastric cancer. Therefore, the combination of
both methods is for complementary evaluation.
The limitations of this study are small sample sizes, es-
pecially in T1 stage, T2 stage, and T4 stage. We had used
the appropriate statistical methods to eliminate bias; how-
ever, in order to get more accurate results, we need further
studies to increase the sample size. Although there was a
small number of patients listed in the study, there were 40
cases included. It was appropriate to use the χ2 test; thus,
the conclusion was basically acceptable. Of course, the re-
search is being done until now, and we will take larger
sample sizes to make the results more reliable.Conclusions
In summary, the combination of enhanced CT scanning
and oral contrast echo-enhanced ultrasonography im-
aging for preoperative T staging evaluation in gastric
cancer patients is a simple clinical application therapy
with a higher accuracy. It is an important and accurate
method for gastric cancer therapy.
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